Pasithea Raises $60M to Advance MEK Program and R&D Pipeline
Miami, Florida, November 28, 2025 Pasithea Therapeutics has announced the pricing of a $60 million public offering ,strengthening its...
RASopathies
Advertisement
Advertisement
